Guillain-Barré syndrome (GBS) is a post-infectious autoimmune polyneuropathy regulated by pro- and anti-inflammatory cytokines; TNFA polymorphisms may exert immune pathogenic roles in GBS. We assessed TNFA promoter region polymorphisms (-238G/A, -308G/A, -857C/T, -863C/A) in Bangladeshi patients with GBS (n = 300) and healthy controls (n = 300) by PCR-RFLP and ASO-PCR. TNFA -863CA was significantly associated with GBS disease susceptibility (P = 0.0154) and disease severity (P = 0.0492). TNFA -238A allele was more frequent among anti-ganglioside (GM1) antibody-positive patients (P = 0.0092) and -863AA associated with AMAN subtype of GBS (P = 0.0398). TNFA -863C/A may contribute to GBS severity and pathogenesis in Bangladeshi patients.

, , , , ,
doi.org/10.1016/j.jneuroim.2017.06.005, hdl.handle.net/1765/100679
Journal of Neuroimmunology
Department of Medical Microbiology and Infectious Diseases

Jahan, I. (Israt), Ahammad, R.U. (Rijwan U.), Farzana, K.S. (Kaniz S.), Khalid, M.M. (Mir M.), Islam, M.B. (Mohammad B.), Rahman, M.I. (Mohammad I.), … Islam, Z. (2017). Tumor necrosis factor-alpha -863C/A polymorphism is associated with Guillain–Barré syndrome in Bangladesh. Journal of Neuroimmunology, 310, 46–50. doi:10.1016/j.jneuroim.2017.06.005